Hospira Names Svend Andersen to Lead Europe, Middle East and Africa

LEAMINGTON SPA, England, October 4, 2010 – Hospira (NYSE: HSP), a global specialty pharmaceutical and medication
delivery company, announced today that Svend Andersen has been named
corporate vice president and president, Europe, Middle East and Africa
(EMEA). In this capacity, he will be responsible for developing strategy,
delivering growth and attaining market leadership in the EMEA region.
Andersen, 48, [...]

Almac’s North American Headquarters Opens its Doors for Audits

SOUDERTON, Pennsylvania, October 4, 2010 – Almac has officially begun hosting customer audits onsite at the new
North American Headquarters. Nine companies have already been given a tour of
the new facility by Business Development staff. Almac has also hosted three
of five "audit open houses" in which multiple customers are free to attend.
The audits have been [...]

Elsevier Launches New Journal: Developmental Cognitive Neuroscience

A Journal for Cognitive, Affective and Social Developmental Cognitive Neuroscience

OXFORD, England, October 4, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and solutions, is pleased to announce the launch of a
new journal, Developmental Cognitive Neuroscience. (
www.elsevier.com/wps/find/journaldescription.cws_home/722734/descripti
on) Published quarterly, print copies of the first issue will be available at
the Society for [...]

Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award

NEUCHATEL, Switzerland, October 4, 2010 – Elsevier Properties SA today congratulated its Research and Development
Director, Professor Dr. Alexander (Sandy) Lawson, for receiving the 2011
Herman Skolnik Award. Presented by the American Chemical Society (ACS)
Division of Chemical Information (CINF), the award recognizes outstanding
contributions to and achievements in the theory and practice of chemical
information science and related [...]

Medtronic Announces Collaboration With Tissuemed for Exclusive Distribution of Innovative Neurosurgical Film

MINNEAPOLIS, October 4, 2010 – Medtronic, Inc. (NYSE: MDT) today announced it will distribute Obex
NeuroFilm(TM) Cerebrospinal Fluid Barrier in markets outside the US in
collaboration with Tissuemed, a leading company in the research, development,
design and manufacture of products utilizing adhesive polymer technology for
medical applications.

Under the terms of its agreement with Tissuemed, [...]

Concentric Medical Announces Product and Procedure Reimbursement as Well as Full Commercialization of the Merci Retriever(R) in Japan

MOUNTAIN VIEW, California, October 4, 2010 – Concentric Medical, Inc., the global leader in devices for clot removal
in ischemic stroke patients, today announced that the Merci Retriever(R) has
recently received both product and procedure reimbursement from the Japanese
Ministry of Health, Labor and Welfare. The Merci Retriever is a
catheter-based medical device that physicians at stroke centers [...]

ProteoTech and Tasly Pharmaceuticals Announce Alzheimer’s Disease Drug Development Agreement for Exebryl-1(R)

Potential disease-modifying Alzheimer's treatment targeting beta-amyloid and tau protein advancing through collaboration between ProteoTech Inc. and major Chinese company, Tasly Pharmaceuticals.

KIRKLAND, Washington, October 4, 2010 – Tasly Pharmaceutical Co., Ltd. (Tianjin, China) and ProteoTech, Inc.
(Kirkland, WA, USA) today announced an agreement to co-develop ProteoTech's
novel small molecule therapeutic, Exebryl-1(R), for the treatment of
mild-to-moderate Alzheimer's disease. [...]

Elsevier Online Opinion Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level

AMSTERDAM, October 4, 2010 – On Tuesday, September 28, Elsevier released the results of a
"Future of Search and Discovery" opinion survey that was designed to provide
a "quick pulse" of the attitudes of researchers through an informal online
opinion poll. While it was not a scientific research study nor labeled as
such in the release, we should [...]

BridgePoint Medical(R), Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss(R) and Stingray(R) CTO Recanalization System

MINNEAPOLIS, October 4, 2010 – BridgePoint Medical, Inc., a medical device company focused on coronary
and peripheral catheter-based systems for chronic total occlusion (CTO)
recanalization, announced the completion of the FAST-CTOs study.
BridgePoint's 16 center, 147 patient U.S. FAST-CTOs (Facilitated Antegrade
Steering Technique for the treatment of Chronic Total Occlusions) study was
designed to assess the safety and effectiveness [...]